MC-2872

Patient Name : MS CHAITRA TR

BENGALURU, Karnataka
Age/Gender : 27 Year(s) / Female Sample Drawn Date : 2022-04-29 13:21
Sample Type : SERUM Sample Regd Date : 2022-04-29 13:27 MEDID : 9855684
Sample ID : Aa2436419 Sample Auth Date : 2022-04-29 16:51 █▐
█▐
█▐
▌▐█
▌▐█
▌▐█
▌█
▌█
▌█
█▐█
█▐█
█▐█
▌▐▐▌▐█
▌▐▐▌▐█
▌▐▐▌▐█
█▐█
█▐█
█▐█
▌▐█▐▌█▌▌▐█
▌▐█▐▌█▌▌▐█
▌▐█▐▌█▌▌▐█
█▐▐▌▐█
█▐▐▌▐█
█▐▐▌▐█
█
█
█
▌█▌▐█▐
▌█▌▐█▐
▌█▌▐█▐
█
█
█
▌▐█
▌▐█
▌▐█
█▐
█▐
█▐
█
█
█
█▌▌▐█▐▌▐
█▌▌▐█▐▌▐
█▌▌▐█▐▌▐
█▌█
█▌█
█▌█
▌
▌
▌
▌
▌
▌
█▐▌
█▐▌
█▐▌
█▌▌█
█▌▌█
█▌▌█
█▐ ▌▐█ ▌█ █▐█ ▌▐▐▌▐█ █▐█ ▌▐█▐▌█▌▌▐█ █▐▐▌▐█ █ ▌█▌▐█▐ █ ▌▐█ █▐ █ █▌▌▐█▐▌▐ █▌█ ▌ ▌ █▐▌ █▌▌█
█▐ ▌▐█ ▌█ █▐█ ▌▐▐▌▐█ █▐█ ▌▐█▐▌█▌▌▐█ █▐▐▌▐█ █ ▌█▌▐█▐ █ ▌▐█ █▐ █ █▌▌▐█▐▌▐ █▌█ ▌ ▌ █▐▌ █▌▌█

Ref. Doctor
█▐ ▌▐█ ▌█ █▐█ ▌▐▐▌▐█ █▐█ ▌▐█▐▌█▌▌▐█ █▐▐▌▐█ █ ▌█▌▐█▐ █ ▌▐█ █▐ █ █▌▌▐█▐▌▐ █▌█ ▌ ▌ █▐▌ █▌▌█

: Dr. █▐
█▐
▌▐█
▌▐█
▌█
▌█
█▐█
█▐█
▌▐▐▌▐█
▌▐▐▌▐█
█▐█
█▐█
▌▐█▐▌█▌▌▐█
▌▐█▐▌█▌▌▐█
█▐▐▌▐█
█▐▐▌▐█
█
█
▌█▌▐█▐
▌█▌▐█▐
█
█
▌▐█
▌▐█
█▐
█▐
█
█
█▌▌▐█▐▌▐
█▌▌▐█▐▌▐
█▌█
█▌█
▌
▌
▌
▌
█▐▌
█▐▌
█▌▌█
█▌▌█

CLINICAL BIOCHEMISTRY

TEST DESCRIPTION RESULT UNITS BIOLOGICAL REFERENCE RANGES

Folate Serum (Folic Acid)* 6.8 ng/mL 0.35 - 3.37 : Deficient
(Method: Electro Chemiluminescence)
3.38 - 5.38 : Indeterminate
> 5.38 : Normal
Vistit 1 Visit 2 Visit 3 Visit 4 Visit 5 Visit 6

Prognosis Chart 2022/04/29

1 HIGH 0.0

3 NORMAL 6.8

4 CAUTIOUS LOW 0.0

5 LOW 0.0

Phosphorus 3.6 mg/dL 2.5 - 4.5

(Method: Phosphomolybdate reduction)

Calcium 8.8 mg/dL 8.6 - 10.3

(Method: Spectrophotometry(Cresol Complex))

Vistit 1 Visit 2 Visit 3 Visit 4 Visit 5 Visit 6

Prognosis Chart 2022/04/29

1 SEVERE HYPERCALCEMI 0.0

2 HYPERCALCEMIA 0.0

3 NORMAL 8.8

4 HYPOCALCEMIA 0.0

estimated Glomerular Filtration Rate (eGFR) 103 mL/min 90-120 mL/min/1.73 m2

(Method: Calculated)

Dr BKP Prasanna
Scan QR Code to check the MD, Pathologist
16|3330|255

authencity of the report

Page 1 of 7
This is an electronically authenticated report. Report Printed Date : 29/04/2022 19:41:46
NOTE : Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient
Indicate NABL MC-2872 Accredited Parameter when processed in HQ MEDCIS PATHLABS, Hyderabad
 MC-2872

Patient Name : MS CHAITRA TR

BENGALURU, Karnataka
Age/Gender : 27 Year(s) / Female Sample Drawn Date : 2022-04-29 13:21
Sample Type : SERUM Sample Regd Date : 2022-04-29 13:27 MEDID : 9855684
Sample ID : Aa2436419 Sample Auth Date : 2022-04-29 16:51 █▐
█▐
█▐
▌▐█
▌▐█
▌▐█
▌█
▌█
▌█
█▐█
█▐█
█▐█
▌▐▐▌▐█
▌▐▐▌▐█
▌▐▐▌▐█
█▐█
█▐█
█▐█
▌▐█▐▌█▌▌▐█
▌▐█▐▌█▌▌▐█
▌▐█▐▌█▌▌▐█
█▐▐▌▐█
█▐▐▌▐█
█▐▐▌▐█
█
█
█
▌█▌▐▌▐
▌█▌▐▌▐
▌█▌▐▌▐
█▌▌▐█▐▌▐
█▌▌▐█▐▌▐
█▌▌▐█▐▌▐
█
█
█
█▌▌▐█▐▌▐
█▌▌▐█▐▌▐
█▌▌▐█▐▌▐
█▌█
█▌█
█▌█
▌▌██
▌▌██
▌▌██
▐▌
▐▌
▐▌
█▌▌█
█▌▌█
█▌▌█
█▐ ▌▐█ ▌█ █▐█ ▌▐▐▌▐█ █▐█ ▌▐█▐▌█▌▌▐█ █▐▐▌▐█ █ ▌█▌▐▌▐ █▌▌▐█▐▌▐ █ █▌▌▐█▐▌▐ █▌█ ▌▌██ ▐▌ █▌▌█
█▐ ▌▐█ ▌█ █▐█ ▌▐▐▌▐█ █▐█ ▌▐█▐▌█▌▌▐█ █▐▐▌▐█ █ ▌█▌▐▌▐ █▌▌▐█▐▌▐ █ █▌▌▐█▐▌▐ █▌█ ▌▌██ ▐▌ █▌▌█

Ref. Doctor
█▐ ▌▐█ ▌█ █▐█ ▌▐▐▌▐█ █▐█ ▌▐█▐▌█▌▌▐█ █▐▐▌▐█ █ ▌█▌▐▌▐ █▌▌▐█▐▌▐ █ █▌▌▐█▐▌▐ █▌█ ▌▌██ ▐▌ █▌▌█

: Dr. █▐
█▐
▌▐█
▌▐█
▌█
▌█
█▐█
█▐█
▌▐▐▌▐█
▌▐▐▌▐█
█▐█
█▐█
▌▐█▐▌█▌▌▐█
▌▐█▐▌█▌▌▐█
█▐▐▌▐█
█▐▐▌▐█
█
█
▌█▌▐▌▐
▌█▌▐▌▐
█▌▌▐█▐▌▐
█▌▌▐█▐▌▐
█
█
█▌▌▐█▐▌▐
█▌▌▐█▐▌▐
█▌█
█▌█
▌▌██
▌▌██
▐▌
▐▌
█▌▌█
█▌▌█

CLINICAL BIOCHEMISTRY

TEST DESCRIPTION RESULT UNITS BIOLOGICAL REFERENCE RANGES

LIVER FUNCTION TEST
Bilirubin Total 0.4 mg/dL 0 - 1.0
(Method: Diazotised Sulphanilic Acid)

Bilirubin Direct 0.1 mg/dL 0 - 0.3

(Method: Diazotised Sulphanilic Acid)

Bilirubin Indirect 0.3 mg/dL 0 - 1.0

(Method: Calculation)

Alkaline Phosphatase (ALP) 85 U/L 50 – 136 : > 16 Years

(Method: AMP Buffer)

Alanine Transaminase (ALT/SGPT)) 13 U/L < 33

(Method: UV with pyridoxal - 5 - phosphate)

Aspartate Aminotransferase(AST/SGOT) 14 U/L Upto 32

(Method: UV with Pyridoxal-5-phosphate)

Y- Glutamyl Transferase (GGT) 11 U/L 5 - 36

(Method: g-Glut-3-carboxy-4 nitro)

Protein Total 7.2 g/dL 6.6 - 8.7

(Method: BIURET)

Albumin 4.5 g/dL 3.5 - 5.4

(Method: Bromocresol Purple)

Globulin 2.7 g/dL 2.5 - 3.5

(Method: Calculated)

Albumin / Globulin Ratio 1.7 1.0 - 2.1

(Method: Calculated)

Dr BKP Prasanna
Scan QR Code to check the MD, Pathologist
16|3330|255

authencity of the report

Page 2 of 7
This is an electronically authenticated report. Report Printed Date : 29/04/2022 19:41:46
NOTE : Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient
Indicate NABL MC-2872 Accredited Parameter when processed in HQ MEDCIS PATHLABS, Hyderabad
 MC-2872

Patient Name : MS CHAITRA TR

BENGALURU, Karnataka
Age/Gender : 27 Year(s) / Female Sample Drawn Date : 2022-04-29 13:21
Sample Type : SERUM Sample Regd Date : 2022-04-29 13:27 MEDID : 9855684
Sample ID : Aa2436419 Sample Auth Date : 2022-04-29 16:51 █▐
█▐
█▐
▌▐█
▌▐█
▌▐█
▌█
▌█
▌█
█▐█
█▐█
█▐█
▌▐▐▌▐█
▌▐▐▌▐█
▌▐▐▌▐█
█▐█
█▐█
█▐█
▌▐█▐▌█▌▌▐█
▌▐█▐▌█▌▌▐█
▌▐█▐▌█▌▌▐█
█▐▐▌▐█
█▐▐▌▐█
█▐▐▌▐█
█
█
█
▌█▌▐▌▐▐█
▌█▌▐▌▐▐█
▌█▌▐▌▐▐█
█
█
█
█▌▐▐
█▌▐▐
█▌▐▐
█
█
█
█▌▌▐█▐▌▐
█▌▌▐█▐▌▐
█▌▌▐█▐▌▐
█▌█
█▌█
█▌█
█▐▌▐▌▐▌
█▐▌▐▌▐▌
█▐▌▐▌▐▌
█▌▌█
█▌▌█
█▌▌█
█▐ ▌▐█ ▌█ █▐█ ▌▐▐▌▐█ █▐█ ▌▐█▐▌█▌▌▐█ █▐▐▌▐█ █ ▌█▌▐▌▐▐█ █ █▌▐▐ █ █▌▌▐█▐▌▐ █▌█ █▐▌▐▌▐▌ █▌▌█
█▐ ▌▐█ ▌█ █▐█ ▌▐▐▌▐█ █▐█ ▌▐█▐▌█▌▌▐█ █▐▐▌▐█ █ ▌█▌▐▌▐▐█ █ █▌▐▐ █ █▌▌▐█▐▌▐ █▌█ █▐▌▐▌▐▌ █▌▌█

Ref. Doctor
█▐ ▌▐█ ▌█ █▐█ ▌▐▐▌▐█ █▐█ ▌▐█▐▌█▌▌▐█ █▐▐▌▐█ █ ▌█▌▐▌▐▐█ █ █▌▐▐ █ █▌▌▐█▐▌▐ █▌█ █▐▌▐▌▐▌ █▌▌█

: Dr. █▐
█▐
▌▐█
▌▐█
▌█
▌█
█▐█
█▐█
▌▐▐▌▐█
▌▐▐▌▐█
█▐█
█▐█
▌▐█▐▌█▌▌▐█
▌▐█▐▌█▌▌▐█
█▐▐▌▐█
█▐▐▌▐█
█
█
▌█▌▐▌▐▐█
▌█▌▐▌▐▐█
█
█
█▌▐▐
█▌▐▐
█
█
█▌▌▐█▐▌▐
█▌▌▐█▐▌▐
█▌█
█▌█
█▐▌▐▌▐▌
█▐▌▐▌▐▌
█▌▌█
█▌▌█

CLINICAL BIOCHEMISTRY

TEST DESCRIPTION RESULT UNITS BIOLOGICAL REFERENCE RANGES

LIPID PROFILE
Cholesterol - Total 104 mg/dL < 200:Desirable
(Method: CHOD/PAP) 200 - 239 :Borderline risk
> 240:High Risk
Cholesterol - HDL 43 mg/dL < 40 : Low
(Method: Direct) 40 - 60 : Optimal
> 60 : Desirable
Cholesterol - LDL 46 mg/dL < 100 : Normal
(Method: Homogeneous enzymatic end point assay) 100 - 129 : Desirable
130 – 159 : Borderline-High
160 – 189 : High
> 190 : Very High
Cholesterol VLDL 15 mg/dL 7-40
(Method: Calculation)

Triglycerides 78 mg/dL < 150 :Normal

(Method: Lipase / Glycerol Kinase) 150–199 :Borderline-High
200–499 :High
> 500 :Very High
Total cholesterol/HDL ratio 2.4 0 - 5.0
(Method: Calculation)

LDL / HDL Ratio 1.1 ratio 0 - 3.5

(Method: Calculation)

Dr BKP Prasanna
Scan QR Code to check the MD, Pathologist
16|3330|255

authencity of the report

Page 3 of 7
This is an electronically authenticated report. Report Printed Date : 29/04/2022 19:41:46
NOTE : Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient
Indicate NABL MC-2872 Accredited Parameter when processed in HQ MEDCIS PATHLABS, Hyderabad
 MC-2872

Patient Name : MS CHAITRA TR

BENGALURU, Karnataka
Age/Gender : 27 Year(s) / Female Sample Drawn Date : 2022-04-29 13:21
Sample Type : SERUM Sample Regd Date : 2022-04-29 13:27 MEDID : 9855684
Sample ID : Aa2436419 Sample Auth Date : 2022-04-29 16:51 █▐
█▐
█▐
▌▐█
▌▐█
▌▐█
▌█
▌█
▌█
█▐█
█▐█
█▐█
▌▐▐▌▐█
▌▐▐▌▐█
▌▐▐▌▐█
█▐█
█▐█
█▐█
▌▐█▐▌█▌▌▐█
▌▐█▐▌█▌▌▐█
▌▐█▐▌█▌▌▐█
█▐▐▌▐█
█▐▐▌▐█
█▐▐▌▐█
█
█
█
▌█▌▐█▐▌█▌▌▐█▐▌▐
▌█▌▐█▐▌█▌▌▐█▐▌▐
▌█▌▐█▐▌█▌▌▐█▐▌▐
█
█
█
█▌▌▐█▐▌▐
█▌▌▐█▐▌▐
█▌▌▐█▐▌▐
█▌█
█▌█
█▌█
▌▐█▐▌▐▌
▌▐█▐▌▐▌
▌▐█▐▌▐▌
█▌▌█
█▌▌█
█▌▌█
█▐ ▌▐█ ▌█ █▐█ ▌▐▐▌▐█ █▐█ ▌▐█▐▌█▌▌▐█ █▐▐▌▐█ █ ▌█▌▐█▐▌█▌▌▐█▐▌▐ █ █▌▌▐█▐▌▐ █▌█ ▌▐█▐▌▐▌ █▌▌█
█▐ ▌▐█ ▌█ █▐█ ▌▐▐▌▐█ █▐█ ▌▐█▐▌█▌▌▐█ █▐▐▌▐█ █ ▌█▌▐█▐▌█▌▌▐█▐▌▐ █ █▌▌▐█▐▌▐ █▌█ ▌▐█▐▌▐▌ █▌▌█

Ref. Doctor
█▐ ▌▐█ ▌█ █▐█ ▌▐▐▌▐█ █▐█ ▌▐█▐▌█▌▌▐█ █▐▐▌▐█ █ ▌█▌▐█▐▌█▌▌▐█▐▌▐ █ █▌▌▐█▐▌▐ █▌█ ▌▐█▐▌▐▌ █▌▌█

: Dr. █▐
█▐
▌▐█
▌▐█
▌█
▌█
█▐█
█▐█
▌▐▐▌▐█
▌▐▐▌▐█
█▐█
█▐█
▌▐█▐▌█▌▌▐█
▌▐█▐▌█▌▌▐█
█▐▐▌▐█
█▐▐▌▐█
█
█
▌█▌▐█▐▌█▌▌▐█▐▌▐
▌█▌▐█▐▌█▌▌▐█▐▌▐
█
█
█▌▌▐█▐▌▐
█▌▌▐█▐▌▐
█▌█
█▌█
▌▐█▐▌▐▌
▌▐█▐▌▐▌
█▌▌█
█▌▌█

CLINICAL BIOCHEMISTRY

TEST DESCRIPTION RESULT UNITS BIOLOGICAL REFERENCE RANGES

KIDNEY BASIC SCREEN
Creatinine(Serum) 0.8 mg/dL 0.5 - 1.0
(Method: JAFFE-Kinetic)

Urea (Serum) 17 mg/dL Upto 50

(Method: UV-Kinetic)

Blood Urea Nitrogen (BUN) 7.9 mg/dL 7 - 18

(Method: Calculation)

Blood Urea Nitrogen (BUN)/Creatinine 9.9 Ratio 6 - 22

(Method: Calculation)

Sodium 138 mmol/L 135 - 145

(Method: Ion selective electrode (ISE Direct))

Potassium 4.0 mmol/L 3.8 - 5.2

(Method: Ion selective electrode (ISE Direct))

Chloride 103 mmol/L 94-108

(Method: ISE Direct)

Uric Acid* 4.8 mg/dL 2.4 - 6.6

(Method: Uricase)

Dr BKP Prasanna
Scan QR Code to check the MD, Pathologist
16|3330|255

authencity of the report

Page 4 of 7
This is an electronically authenticated report. Report Printed Date : 29/04/2022 19:41:46
NOTE : Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient
Indicate NABL MC-2872 Accredited Parameter when processed in HQ MEDCIS PATHLABS, Hyderabad
 MC-2872

Patient Name : MS CHAITRA TR

BENGALURU, Karnataka
Age/Gender : 27 Year(s) / Female Sample Drawn Date : 2022-04-29 13:21
Sample Type : SERUM Sample Regd Date : 2022-04-29 13:27 MEDID : 9855684
Sample ID : Aa2436419 Sample Auth Date : 2022-04-29 16:51 █▐
█▐
█▐
▌▐█
▌▐█
▌▐█
▌█
▌█
▌█
█▐█
█▐█
█▐█
▌▐▐▌▐█
▌▐▐▌▐█
▌▐▐▌▐█
█▐█
█▐█
█▐█
▌▐█▐▌█▌▌▐█
▌▐█▐▌█▌▌▐█
▌▐█▐▌█▌▌▐█
█▐▐▌▐█
█▐▐▌▐█
█▐▐▌▐█
█
█
█
▌█▌▐▌▐█▐
▌█▌▐▌▐█▐
▌█▌▐▌▐█▐
█
█
█
▌▐█▐
▌▐█▐
▌▐█▐
█
█
█
█▌▌▐█▐▌▐
█▌▌▐█▐▌▐
█▌▌▐█▐▌▐
█▌█
█▌█
█▌█
▌
▌
▌
█▌█▐▌
█▌█▐▌
█▌█▐▌
█▌▌█
█▌▌█
█▌▌█
█▐ ▌▐█ ▌█ █▐█ ▌▐▐▌▐█ █▐█ ▌▐█▐▌█▌▌▐█ █▐▐▌▐█ █ ▌█▌▐▌▐█▐ █ ▌▐█▐ █ █▌▌▐█▐▌▐ █▌█ ▌ █▌█▐▌ █▌▌█
█▐ ▌▐█ ▌█ █▐█ ▌▐▐▌▐█ █▐█ ▌▐█▐▌█▌▌▐█ █▐▐▌▐█ █ ▌█▌▐▌▐█▐ █ ▌▐█▐ █ █▌▌▐█▐▌▐ █▌█ ▌ █▌█▐▌ █▌▌█

Ref. Doctor
█▐ ▌▐█ ▌█ █▐█ ▌▐▐▌▐█ █▐█ ▌▐█▐▌█▌▌▐█ █▐▐▌▐█ █ ▌█▌▐▌▐█▐ █ ▌▐█▐ █ █▌▌▐█▐▌▐ █▌█ ▌ █▌█▐▌ █▌▌█

: Dr. █▐
█▐
▌▐█
▌▐█
▌█
▌█
█▐█
█▐█
▌▐▐▌▐█
▌▐▐▌▐█
█▐█
█▐█
▌▐█▐▌█▌▌▐█
▌▐█▐▌█▌▌▐█
█▐▐▌▐█
█▐▐▌▐█
█
█
▌█▌▐▌▐█▐
▌█▌▐▌▐█▐
█
█
▌▐█▐
▌▐█▐
█
█
█▌▌▐█▐▌▐
█▌▌▐█▐▌▐
█▌█
█▌█
▌
▌
█▌█▐▌
█▌█▐▌
█▌▌█
█▌▌█

CLINICAL BIOCHEMISTRY

TEST DESCRIPTION RESULT UNITS BIOLOGICAL REFERENCE RANGES

THYROID PROFILE II
TriIodothyronine Total (TT3) 72.8 ng/dL 126 – 258 : 1 Yr – 5 Yr
(Method: Electro Chemiluminescence) 96 – 227 : 6 Yr – 15 Yr
91 – 164 : 16 Yr – 18 Yr
60 – 181 : > 18 years
Pregnancy :
1st Trimester : 81 - 190
2nd & 3rd Trimester:100 - 260
TriIodothyronine Free (FT3) 2.81 pg/mL 2.3 - 4.2
(Method: Electro Chemiluminescence) 2.0 - 3.8 : Pregnancy
Thyroxine - Total (TT4) 6.19 ug/dL 4.6 - 10.9
(Method: Electro Chemiluminescence) Pregnancy:
4.6 – 16.5 : 1st Trimester
4.6 – 18.5 : 2nd & 3rd Tri
Thyroxine - Free (FT4) 1.26 ng/dL 0.8 - 2.7 : Adults (21 - 87 Yrs)
(Method: Electro Chemiluminescence)

Pregnancy

0.7 - 2.0 : First Trimester

0.5 - 1.6 : 2nd and 3rd Tri

(Ref:TIETZ)
Thyroid Stimulating Hormone (TSH) 49.85 uIU/mL 0.46 – 8.10 : 1 Yrs – 5 Yrs
(Method: Ultra sensitive chemiluminescence) 0.36 – 5.80 : 6 Yrs – 18 Yrs
0.35 – 5.50 : 18 Yrs – 55 Yrs
0.50 – 8.90 : >55 yrs
Pregnancy Ranges::::
Ist Tri :0.1 - 2.5
IInd Tri :0.2 - 3.0
IIIrd Tri:0.3 - 3.0

Dr BKP Prasanna
Scan QR Code to check the MD, Pathologist
16|3330|255

authencity of the report

Page 5 of 7
This is an electronically authenticated report. Report Printed Date : 29/04/2022 19:41:46
NOTE : Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient
Indicate NABL MC-2872 Accredited Parameter when processed in HQ MEDCIS PATHLABS, Hyderabad
 MC-2872

Patient Name : MS CHAITRA TR

BENGALURU, Karnataka
Age/Gender : 27 Year(s) / Female Sample Drawn Date : 2022-04-29 13:21
Sample Type : SERUM Sample Regd Date : 2022-04-29 13:27 MEDID : 9855684
Sample ID : Aa2436419 Sample Auth Date : 2022-04-29 16:51 █▐
█▐
█▐
▌▐█
▌▐█
▌▐█
▌█
▌█
▌█
█▐█
█▐█
█▐█
▌▐▐▌▐█
▌▐▐▌▐█
▌▐▐▌▐█
█▐█
█▐█
█▐█
▌▐█▐▌█▌▌▐█
▌▐█▐▌█▌▌▐█
▌▐█▐▌█▌▌▐█
█▐▐▌▐█
█▐▐▌▐█
█▐▐▌▐█
█
█
█
▌█▌▐▌█▌▐
▌█▌▐▌█▌▐
▌█▌▐▌█▌▐
█▌▐▐▌▐
█▌▐▐▌▐
█▌▐▐▌▐
█
█
█
█▌▌▐█▐▌▐
█▌▌▐█▐▌▐
█▌▌▐█▐▌▐
█▌█
█▌█
█▌█
██
██
██
▌▐▐▌
▌▐▐▌
▌▐▐▌
█▌▌█
█▌▌█
█▌▌█
█▐ ▌▐█ ▌█ █▐█ ▌▐▐▌▐█ █▐█ ▌▐█▐▌█▌▌▐█ █▐▐▌▐█ █ ▌█▌▐▌█▌▐ █▌▐▐▌▐ █ █▌▌▐█▐▌▐ █▌█ ██ ▌▐▐▌ █▌▌█
█▐ ▌▐█ ▌█ █▐█ ▌▐▐▌▐█ █▐█ ▌▐█▐▌█▌▌▐█ █▐▐▌▐█ █ ▌█▌▐▌█▌▐ █▌▐▐▌▐ █ █▌▌▐█▐▌▐ █▌█ ██ ▌▐▐▌ █▌▌█

Ref. Doctor
█▐ ▌▐█ ▌█ █▐█ ▌▐▐▌▐█ █▐█ ▌▐█▐▌█▌▌▐█ █▐▐▌▐█ █ ▌█▌▐▌█▌▐ █▌▐▐▌▐ █ █▌▌▐█▐▌▐ █▌█ ██ ▌▐▐▌ █▌▌█

: Dr. █▐
█▐
▌▐█
▌▐█
▌█
▌█
█▐█
█▐█
▌▐▐▌▐█
▌▐▐▌▐█
█▐█
█▐█
▌▐█▐▌█▌▌▐█
▌▐█▐▌█▌▌▐█
█▐▐▌▐█
█▐▐▌▐█
█
█
▌█▌▐▌█▌▐
▌█▌▐▌█▌▐
█▌▐▐▌▐
█▌▐▐▌▐
█
█
█▌▌▐█▐▌▐
█▌▌▐█▐▌▐
█▌█
█▌█
██
██
▌▐▐▌
▌▐▐▌
█▌▌█
█▌▌█

CLINICAL BIOCHEMISTRY

TEST DESCRIPTION RESULT UNITS BIOLOGICAL REFERENCE RANGES

IRON PROFILE
Iron 60 µg/dL 33 - 193
(Method: Ferene)

Iron Binding Capacity - Total (TIBC)* 382 µg/dL 240-450

(Method: Ferrozine)

Transferrin 259.9 ug/dL 176 - 280

(Method: Immunoturbidometry)

Transferrin % 15.7 % 20-50

(Method: Calculation)

Dr BKP Prasanna
Scan QR Code to check the MD, Pathologist
16|3330|255

authencity of the report

Page 6 of 7
This is an electronically authenticated report. Report Printed Date : 29/04/2022 19:41:46
NOTE : Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient
Indicate NABL MC-2872 Accredited Parameter when processed in HQ MEDCIS PATHLABS, Hyderabad
 MC-2872

Patient Name : MS CHAITRA TR

BENGALURU, Karnataka
Age/Gender : 27 Year(s) / Female Sample Drawn Date : 2022-04-29 13:21
Sample Type : SERUM Sample Regd Date : 2022-04-29 13:27 MEDID : 9855684
Sample ID : Aa2436419 Sample Auth Date : 2022-04-29 16:51 █▐
█▐
█▐
▌▐█
▌▐█
▌▐█
▌█
▌█
▌█
█▐█
█▐█
█▐█
▌▐▐▌▐█
▌▐▐▌▐█
▌▐▐▌▐█
█▐█
█▐█
█▐█
▌▐█▐▌█▌▌▐█
▌▐█▐▌█▌▌▐█
▌▐█▐▌█▌▌▐█
█▐▐▌▐█
█▐▐▌▐█
█▐▐▌▐█
█
█
█
▌█▌▐█▐▌█▌█▌▐▐▌▐
▌█▌▐█▐▌█▌█▌▐▐▌▐
▌█▌▐█▐▌█▌█▌▐▐▌▐
█
█
█
█▌▌▐█▐▌▐
█▌▌▐█▐▌▐
█▌▌▐█▐▌▐
█▌█
█▌█
█▌█
▌▐
▌▐
▌▐
█
█
█
▐▌
▐▌
▐▌
█▌▌█
█▌▌█
█▌▌█
█▐ ▌▐█ ▌█ █▐█ ▌▐▐▌▐█ █▐█ ▌▐█▐▌█▌▌▐█ █▐▐▌▐█ █ ▌█▌▐█▐▌█▌█▌▐▐▌▐ █ █▌▌▐█▐▌▐ █▌█ ▌▐ █ ▐▌ █▌▌█
█▐ ▌▐█ ▌█ █▐█ ▌▐▐▌▐█ █▐█ ▌▐█▐▌█▌▌▐█ █▐▐▌▐█ █ ▌█▌▐█▐▌█▌█▌▐▐▌▐ █ █▌▌▐█▐▌▐ █▌█ ▌▐ █ ▐▌ █▌▌█

Ref. Doctor
█▐ ▌▐█ ▌█ █▐█ ▌▐▐▌▐█ █▐█ ▌▐█▐▌█▌▌▐█ █▐▐▌▐█ █ ▌█▌▐█▐▌█▌█▌▐▐▌▐ █ █▌▌▐█▐▌▐ █▌█ ▌▐ █ ▐▌ █▌▌█

: Dr. █▐
█▐
▌▐█
▌▐█
▌█
▌█
█▐█
█▐█
▌▐▐▌▐█
▌▐▐▌▐█
█▐█
█▐█
▌▐█▐▌█▌▌▐█
▌▐█▐▌█▌▌▐█
█▐▐▌▐█
█▐▐▌▐█
█
█
▌█▌▐█▐▌█▌█▌▐▐▌▐
▌█▌▐█▐▌█▌█▌▐▐▌▐
█
█
█▌▌▐█▐▌▐
█▌▌▐█▐▌▐
█▌█
█▌█
▌▐
▌▐
█
█
▐▌
▐▌
█▌▌█
█▌▌█

CLINICAL BIOCHEMISTRY

TEST DESCRIPTION RESULT UNITS BIOLOGICAL REFERENCE RANGES

VITAMIN PROFILE
Vitamin - B12 337.8 pg/mL 200 - 911
(Method: Chemiluminescence)

25-Hydroxy Vitamin D Total (D2 & D3) 17.3 ng/mL

(Method: Electro Chemiluminescence)

Dr BKP Prasanna
Scan QR Code to check the MD, Pathologist
16|3330|255

authencity of the report

Page 7 of 7
This is an electronically authenticated report. Report Printed Date : 29/04/2022 19:41:46
NOTE : Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient
Indicate NABL MC-2872 Accredited Parameter when processed in HQ MEDCIS PATHLABS, Hyderabad